Inflammatory Cell Infiltration
Inflammatory Cell Infiltration - Related Videos
07:03
Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration
0 Views •
Cited by 155 •
2017
The health status of the lung is reflected by the type and number of immune cells that are present in the bronchioles of the lung. We describe a bronchoalveolar lavage technique that allows the isolation and study of nonadherent cells and soluble factors from the lower respiratory tract of mice.
06:44
Isolation of Brain-infiltrating Leukocytes
0 Views •
Cited by 33 •
2011
A rapid method to obtain infiltrating leukocytes from the murine brain is described. This method utilizes a continuous Percoll gradient and discontinuous Ficoll gradient to select and purify the leukocyte-enriched layer. Isolated leukocytes may then be characterized by flow cytometric measurements.
12:52
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
0 Views •
Cited by 17 •
2015
Presented here is a straightforward method for the isolation and flow cytometric analysis of glioma-infiltrating peripheral blood mononuclear cells that yields time-dependent quantitative data on the number and activation status of immune cells entering the early brain tumor microenvironment.
02:02
A Three-Dimensional Co-culture Model of Infiltrating T Cells in Tumor Spheroids
0 Views •
2025
This video demonstrates a method to establish a three-dimensional tumor spheroid and T cell co-culture. An agarose cast with microwells containing tumor spheroids is prepared, followed by the addition of T cells. After incubation, this setup allows studying the interaction of T cells with tumor spheroids in a controlled three-dimensional environment.
04:00
Immunohistochemistry to Study the Relationship Between Macrophages and Infiltrated Immune Cells
0 Views •
2025
This video demonstrates a technique to quantify the relative ratio of macrophages among the total infiltrated immune cell populations in temporal artery biopsy. The immunohistochemical staining of a tissue section affected by autoimmune disease selectively stains the immune cells with specific receptors to visually differentiate them from the rest of the cells.
FAQs
These mediators act in sequence and in combination. Chemokines and cytokines generate inflammatory signals, while adhesion molecules promote leukocyte attachment to the vascular endothelium. Once circulating cells adhere, the same signaling environment guides their movement through the vessel wall toward the affected tissue. This coordination determines where immune cells accumulate and links mediator activity with local host defense.
Neutrophils, monocytes, lymphocytes, and other leukocytes can represent different cellular contributions to an inflammatory response. Measuring their presence separately helps distinguish the pattern of tissue involvement rather than treating all infiltrating cells as equivalent. That distinction is pharmacologically useful because a treatment may alter recruitment of one population more strongly than another, producing different effects on inflammation and tissue damage.
Drug effects can be examined at several stages of recruitment, including mediator production, leukocyte adhesion to the endothelium, migration through the vessel wall, and accumulation within tissue. Separating these stages helps clarify how an anti-inflammatory treatment works. For example, reduced tissue infiltration may reflect altered signaling, impaired attachment, restricted migration, or a combination of these mechanisms.
The recruited cells help coordinate responses to infection, injury, or other inflammatory stimuli and can support tissue repair. However, the same accumulation can be associated with tissue damage when inflammatory activity becomes harmful. Consequently, infiltration measurements provide more than a cell count: they help connect immune recruitment with the balance between protective responses, repair, and adverse tissue effects.
Pharmacology studies assess the extent and cellular composition of infiltration in affected tissue, focusing on populations such as neutrophils, monocytes, or lymphocytes. The analysis can then be compared across inflammatory conditions and treatment groups to determine whether a candidate drug changes recruitment. Interpreting both the amount and type of infiltrating cells strengthens conclusions about anti-inflammatory activity.
A change in infiltrating-cell accumulation can indicate that a treatment affects inflammatory mediator production, leukocyte adhesion, migration, or tissue damage. Examining these outcomes helps connect a drug's cellular effects with its overall anti-inflammatory efficacy. The findings may also show whether treatment modifies the inflammatory process broadly or changes particular components of leukocyte recruitment.
Infiltration analysis can show whether a treatment suppresses inflammatory recruitment while potentially altering tissue responses associated with repair or damage. These observations place efficacy findings in a broader pharmacological context. By relating cellular accumulation to inflammatory disease and tissue effects, researchers can evaluate not only whether a drug reduces inflammation, but also whether its action may produce undesirable consequences.